Pacira Pharmaceuticals buy HC Wainwright
Start price
06.11.23
/
50%
€28.40
Target price
06.11.24
€53.07
Performance (%)
-36.97%
Price
08.08.24
€20.20
Summary
This prediction is currently active. Massive losses of -36.97% have been the result for the BUY prediction by HC_Wainwright. This prediction currently runs until 06.11.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacira Pharmaceuticals | 6.878% | 6.878% |
iShares Core DAX® | 0.393% | -2.618% |
iShares Nasdaq 100 | 0.394% | -10.309% |
iShares Nikkei 225® | 1.038% | -8.365% |
iShares S&P 500 | -0.046% | -4.991% |
Comments by HC_Wainwright for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at HC Wainwright from $63.00 to $57.00. They now have a "buy" rating on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by HC_Wainwright for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€21.20
02.07.24
02.07.24
€53.05
02.07.25
02.07.25
-15.57%
08.08.24
08.08.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
08.05.24
08.05.24
€53.04
08.05.25
08.05.25
-33.21%
08.08.24
08.08.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.20
04.03.24
04.03.24
€52.53
04.03.25
04.03.25
-22.14%
08.08.24
08.08.24